Skin of every tone has the same structure and the same number of melanocytes. What differs is how active those melanocytes are, and that changes which risks matter most.
Risk 1: irritation leaves marks
In melanin-rich skin, inflammation often triggers extra pigment. A breakout, a rash or a harsh product can leave post-inflammatory hyperpigmentation (PIH) that lasts months after the cause has gone.
So a formula that works but irritates can make tone worse. This is why we pair strong actives with calming ingredients: centella in four of our five formulas, plus panthenol, betaine and bisabolol where they’re needed.
Risk 2: light keeps pigment switched on
UV drives pigmentation in all skin. Research also shows long-wave UVA and visible light cause darker, longer-lasting pigmentation in deeper skin tones than in lighter ones.
That is why daily broad-spectrum sunscreen matters as much as any serum. For melasma or stubborn marks, dermatologists often also recommend a tinted sunscreen containing iron oxides, which helps block visible light.
Risk 3: white cast means skipped sunscreen
Many mineral sunscreens leave a grey or purple cast on deeper skin, so people stop wearing them. A sunscreen that isn’t worn protects no one. Hydra-Defense Complex uses modern filters that leave no white cast, so it disappears into the skin.
Risk 4: dryness looks different
On deeper skin tones, a weakened barrier often shows as an ashy, dull look rather than redness. It’s easy to miss, and it often comes before sensitivity. Barrier support, such as ceramides with cholesterol, is part of an everyday routine, not only a rescue step.
How this shapes minimalRX
| Concern | Our approach | Where |
|---|---|---|
| Uneven tone | Slow melanin production and transfer, with antioxidant support | Alpha Arbutin, Centella-B3, C15+ |
| Irritation and PIH | Calming ingredients alongside every strong active | Four of five formulas |
| Sun and white cast | Broad-spectrum filters with no white cast | Hydra-Defense |
| Ashy dryness | Five ceramides, cholesterol and hyaluronic complex | Penta-Ceramide |
Further reading
- Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20–31.
- Mahmoud BH, Ruvolo E, Hexsel CL, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol. 2010;130(8):2092–2097.
